Stayble Therapeutics AB announces the outcome of the exercise of warrants of series TO1
In total, 7,122 warrants were exercised, corresponding to approximately 0.3 percent of the outstanding warrants, for subscription of 7 122 shares at a subscription price of SEK 12.30 per share. Through the exercise of these warrant, Stayble will receive approximately SEK 88 thousand before issuing costs.Background Stayble Therapeutics AB carried out, during the first quarter of 2020 in conjunction to the listing on Nasdaq First North Growth Market, an issue of units where one unit consisted of one newly issued share and one warrant free of charge. Each warrant gives the right to
